TOP TIERMARKET NEWSWIRE
News & sentiment

TANGO THERAPEUTICS I (TNGX) — News & AI sentiment

TANGO THERAPEUTICS I (TNGX) news roundup. 1 story in the last 24 hours, 14 in the past week, 20 over 30 days. Average 24-hour sentiment is 58/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $2.2M — net selling of $2.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 58/100
7d stories
14
avg sentiment 51.6/100
30d stories
20
avg sentiment 53.7/100
Insider net (90d)
$2.2M
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

TNGX news in the last 24 hours, 7 days, 30 days and 90 days

How much TNGX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTNGX storiesAvg AI sentimentRead
Last 24 hours158/100TNGX headlines →
Last 7 days1451.6/100TNGX headlines →
Last 30 days2053.7/100TNGX headlines →
Last 90 days4152.9/100TNGX headlines →

Latest stories on TNGX

20h ago
2d ago
5d ago
5d ago
Wedbush raises Tango Therapeutics stock price target on trial data
Investing.com Analyst Ratings64 · neutralanalyst
5d ago
Tango Therapeutics falls -12.6%
The Fly31 · bearishgeneral
5d ago
Stifel raises Tango Therapeutics stock price target on trial data
Investing.com Analyst Ratings64 · neutralanalyst
5d ago
5d ago
Tango Therapeutics falls -17.5%
The Fly28 · bearishgeneral
5d ago
Why is Tango Therapeutics stock sliding today?
Investing.com Markets38 · neutralgeneral
5d ago
5d ago
5d ago
5d ago
5d ago
Oct 16
Oct 16
Oct 16
Tango Therapeutics stock initiated at outperform by William Blair
Investing.com Analyst Ratings63 · neutralanalyst
Oct 16
Oct 16
JPMorgan reiterates Tango Therapeutics stock rating ahead of ESMO data
Investing.com Analyst Ratings52 · neutralanalyst
Oct 13
Sep 3
Sep 3
Sep 1
H.C. Wainwright raises Tango Therapeutics price target to $68
Investing.com Analyst Ratings61 · neutralanalyst
Aug 18
Aug 18
Open TNGX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →